Correspondence  by unknown
volume data are presented. Did they examine the relation of late
potentials in the first week to ventricular volume?
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Reply
We thank Zaman et al. for their comments. Regarding the timing of
recording of late potentials, as they pointed out, the study by El-Sherif
et al. (1) predated the thrombolytic era. Other studies have found that
late potentials generally do not disappear over time in patients with
postinfarction sustained ventricular tachycardia and that the delayed
(.30 days) appearance of late potentials is a rather rare phenomenon
(2,3). Late potentials recorded up to 2 years after infarction may thus
retain or even increase their prognostic significance. Therefore, there
is no clear conclusion regarding the optimal timing of recording of late
potentials in the reperfusion era. Indeed, the Task Force Committee of
the European Society of Cardiology, American Heart Association and
American College of Cardiology in establishing standards for analysis
of late potentials has stated that “the optimum time for recording the
high-resolution ECG has not been defined . . . ” (4). In our study, 83%
of the patients underwent recording during the 6- to 30-day period,
which El-Sherif et al. (1) found to be the most closely associated with
arrythmic events. In addition, the difference in the prevalence of late
potentials cannot be ascribed to the difference in the timing of
recording between the three groups that we compared (median of 11
days in all three groups, range 5 to 390 days).
The role of late potentials as a predictor of arrhythmic events in a
thrombolyzed cohort is an important and controversial (5) issue but
was outside the scope of our study. Our patients were selected on the
basis of acute Thombolysis in Myocardial Infarction grade 3 patency of
the infarct-related vessel, and the event rate would be expected to be
very low; it is indeed conceivable that in this specific patient subset
(with patent infarct-related arteries), late potentials lose their predic-
tive value. The hypothesis that the difference in late potentials between
thrombolysis and angioplasty may translate into a difference in ar-
rhythmic events will be tested in a large, randomized study. We wish to
point out that we did reference the study by Honhloser et al. (6)
(reference 45 in our article). Those authors showed that even in the
thrombolysis era, the presence of late potentials is predictive of the
occurrence of arrythmic events, although this index was less helpful
than patency of the infarct-related artery. The best predictive value for
arrhythmias in the postinfarction period was the combination of
infarct-related artery patency, left ventricular ejection fraction and late
potentials (6). Likewise, the study by McClements et al. (7), cited by
Zaman et al. in support of their assumption that there is no relation
between late potentials and arrhythmic events in a thrombolyzed
cohort, found the opposite. In that series of survivors of myocardial
infarction, 68% of whom received thrombolytic agents, the authors
concluded that “the signal averaged ECG and left ventricular ejection
fraction are each independently predictive of arryhthmic events after
myocardial infarction. . . .”
Finally, we did not measure left ventricular volume but only left
ventricular ejection fraction, and we therefore cannot examine the
interesting hypothesis that the prognostic value of late potentials in the
first week is related to left ventricular dilation.
PHILIPPE GABRIEL STEG, MD
CARMA KARAM
JEAN-LOUIS GOLMARD
Cardiologie A
Hoˆpital BICHAT
46 rue Henri Huchard
75877 Paris Cedex 18, France
References
1. El Sherif N, Ursell SN, Bekheit S, et al. Prognostic significance of the signal-averaged ECG
depends on the time of recording in the postinfarction period. Am Heart J 1989;118:256–
64.
2. Kuchar DL, Sammel L, Thorburn C. Natural history and prognostic significance of late
potentials up to 5 years after myocardial infarction [abstract]. J Am Coll Cardiol
1990;15:72A.
3. Brembilla-Perrot B, Terrier de la Chaise A, Mechkour M. Evolution de l’ECG haute
amplification sur 2 ans apre`s la phase aigue¨ de l’infarctus d’un myocarde. Arch Mal Coeur
1991;84:1833–6.
4. Breithardt G, Cain ME, El-Sherif N, et al. Standards for analysis of ventricular late
potentials using high-resolution or signal-averaged electrocardiography: a statement by a
task force committee of the European Society of Cardiology, the American Heart
Association and the American College of Cardiology. J Am Coll Cardiol 1991;17:999–1006.
5. Vester EG, Strauer BE. Ventricular late potentials: state of the art and future perspectives.
Eur Heart J 1994;15 Suppl C:34–48.
6. Honhloser SH, Franck P, Klingenheben T, Zabel M, Just H. Open infarct artery, late
potentials and other prognostic factors in patients after acute myocardial infarction in the
thrombolytic era: a prospective trial. Circulation 1994;90:1747–56.
7. McClements BM, Adgey AAJ. Value of signal averaged electrocardiography, radionuclide
ventriculography, Holter monitoring and clinical variables for prediction of arryhthmic
events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol
1993;21:1419–27.
“Prevalence” or “Pretest Likelihood” of
Coronary Artery Disease?
We read with great interest the report of Amanullah et al. (1) on the
diagnostic efficacy of adenosine sestamibi perfusion single-photon
emission computed tomography (SPECT) in women. Detection of
coronary artery disease by noninvasive testing is more difficult in
women than in men, especially in terms of positive predictive values.
One of the causes of this difficulty is the global lower prevalence of
coronary artery disease in women (2,3). The authors report a very high
performance of adenosine sestamibi myocardial perfusion SPECT in
women, and emphasize that these performances are maintained in a
group of women with a low pretest likelihood of coronary artery
disease.
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The authors play on the possible confusion between “pretest
likelihood” and “prevalence” of the disease. The global prevalence of
coronary artery disease in their cohort, which does not appear in the
text, is 64% (83 of 130) for $70% diameter stenosis and 72% (94 of
130) for $50% diameter stenosis. Even in the low pretest likelihood
group (,25%, mean 156 6%), coronary artery disease was present on
coronary angiography in 50% of patients.
It is unusual to have such a prevalence of coronary artery disease in
consecutive women referred for stress SPECT, especially when only
18% presented with typical angina, and 33% presented no symptoms
or nonanginal chest pain. This may explain the good performance of
the test, but it is far from everyday clinical practice.
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Reply
We appreciate the interest of Le Guludec and Sarda in our recent
article (1). Detection of coronary artery disease (CAD) by noninvasive
testing has been more difficult in women than men, principally because
symptoms of myocardial ischemia are less specific in women; there is
an increased incidence of false positive ST segment depression on
exercise electrocardiography, and the overall prevalence of CAD is
lower in women (2–5). However, this prevalence approaches the same
level as that in men by age $75 years (5). Of the total of 201 patients
in our study, 71 had a low likelihood of CAD (,10%), and the other
130 underwent angiography. The sensitivity, specificity and predictive
accuracy of adenosine technetium-99m sestamibi single-photon emis-
sion computed tomography (SPECT) was determined in the catheter-
ized group, and the normalcy rate was determined in the low likelihood
group. Of note, the mean age of the catheterized group was 72 6 10
years, and 57% presented with symptoms of angina pectoris (typical or
atypical angina). These patients were unable to perform exercise and
were referred to adenosine myocardial perfusion imaging in a tertiary
care hospital. Thus, the overall prevalence of CAD in this cohort
would be expected to be higher than that in the general population
referred for noninvasive testing in other clinical settings.
Another factor that increases the prevalence of CAD in patients
undergoing catheterization is the inherent referral bias, whereby
patients with positive scan results are preferentially selected for
catheterization; the prevalence of CAD in both the high and low
likelihood groups in this study should be higher than would be
expected by the prescan likelihood of disease (6). Of 22 patients with
a relatively low prescan likelihood of CAD (,25%) and who under-
went catheterization, the prevalence of CAD ($50% diameter steno-
sis) was 50%. With respect to 71 patients with a low likelihood of CAD
(,10%), on average, by likelihood analysis, 10% (or 7 patients) would
be expected to have CAD. Thus, the overall prevalence of CAD in a
total of 93 patients with ,25% likelihood of CAD could be estimated
at 18 (19%) of 93, appropriate for a group of consecutive women with
this relatively low likelihood of CAD referred for stress nuclear
SPECT. In our catheterized group, the overall prescan likelihood of
CAD was 59 6 30%. Because 73% (95 of 130) had abnormal scan
results, the postscan likelihood of CAD was much higher at 706 36%,
closely approximating the prevalence observed in our catheterized
group of 72% (94 of 130) ($50% diameter stenosis).
The point raised by Le Guludec and Sarda does bring out an
important limitation to using coronary angiography for validation of
noninvasive test results that has previously been described by our
laboratory (6–9). This problem is difficult to avoid unless studies can
be performed in which all patients undergo catheterization regardless
of test results. Because this is unrealistic, a true reference standard is
difficult. The effect of the referral bias is to overestimate the sensitivity
and underestimate the specificity of a test. For this reason, we have
advocated the use of the low likelihood of coronary disease cohort as
a surrogate for test specificity when referral bias is present (8,9).
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Prediction of Infarction by
Stress Echocardiography
Varga et al. (1) analyzed the value of stress echocardiography to
predict the occurence and site of future myocardial infarction (MI).
The authors concluded that of five future MIs, only two are correctly
identified with respect to site; another occurs in a patient with a
previously positive test result, but the vascular territory is different
from the previously identified ischemic area and the remaining two
MIs occur in patients with previously negative stress test results.
Therefore the majority of spontaneous coronary occlusions leading to
MI are unheralded by induced ischemia.
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